Dapsone Pharmacology Summary.
Pharmacology of dapsone
Dapsone (also known as DDS or diaminodiphenyl sulfone) is a medication that is primarily used to treat
leprosy, dermatitis herpetiformis, and various skin conditions. It belongs to the class of sulfone
antibiotics and has both antibacterial and anti-inflammatory properties.
Mechanism of Action:
Dapsone works by inhibiting the production of dihydrofolic acid, which is necessary for the synthesis of
DNA and RNA. This action results in the inhibition of bacterial growth, particularly Mycobacterium
leprae, the causative agent of leprosy. It also has anti-inflammatory properties, which contribute to its
effectiveness in treating skin conditions such as dermatitis herpetiformis.
Pharmacokinetics:
Dapsone is rapidly absorbed after oral administration, with peak plasma concentrations reached within
2 to 8 hours. It is metabolized in the liver and excreted in the urine. The half-life of dapsone ranges from
20 to 30 hours, and its therapeutic effects can last up to several weeks.
Indications:
Dapsone is primarily used to treat leprosy, a chronic bacterial infection that affects the skin, nerves, and
mucous membranes. It is also used to treat dermatitis herpetiformis, a skin condition characterized by
itchy blisters and a gluten-sensitive enteropathy. In addition, dapsone may be used off-label for the
treatment of other skin conditions, such as acne vulgaris, erythema nodosum leprosum, and bullous
pemphigoid.
Adverse effects:
Dapsone is generally well-tolerated, but it may cause a range of adverse effects. The most common side
effects include nausea, vomiting, and abdominal pain. Other adverse effects may include skin rash,
fever, headache, dizziness, and methemoglobinemia (a condition in which the oxygen-carrying capacity
of the blood is reduced). In rare cases, dapsone may cause hemolytic anemia, a potentially life-
threatening condition in which the red blood cells are destroyed.
Pharmacology of dapsone
Dapsone (also known as DDS or diaminodiphenyl sulfone) is a medication that is primarily used to treat
leprosy, dermatitis herpetiformis, and various skin conditions. It belongs to the class of sulfone
antibiotics and has both antibacterial and anti-inflammatory properties.
Mechanism of Action:
Dapsone works by inhibiting the production of dihydrofolic acid, which is necessary for the synthesis of
DNA and RNA. This action results in the inhibition of bacterial growth, particularly Mycobacterium
leprae, the causative agent of leprosy. It also has anti-inflammatory properties, which contribute to its
effectiveness in treating skin conditions such as dermatitis herpetiformis.
Pharmacokinetics:
Dapsone is rapidly absorbed after oral administration, with peak plasma concentrations reached within
2 to 8 hours. It is metabolized in the liver and excreted in the urine. The half-life of dapsone ranges from
20 to 30 hours, and its therapeutic effects can last up to several weeks.
Indications:
Dapsone is primarily used to treat leprosy, a chronic bacterial infection that affects the skin, nerves, and
mucous membranes. It is also used to treat dermatitis herpetiformis, a skin condition characterized by
itchy blisters and a gluten-sensitive enteropathy. In addition, dapsone may be used off-label for the
treatment of other skin conditions, such as acne vulgaris, erythema nodosum leprosum, and bullous
pemphigoid.
Adverse effects:
Dapsone is generally well-tolerated, but it may cause a range of adverse effects. The most common side
effects include nausea, vomiting, and abdominal pain. Other adverse effects may include skin rash,
fever, headache, dizziness, and methemoglobinemia (a condition in which the oxygen-carrying capacity
of the blood is reduced). In rare cases, dapsone may cause hemolytic anemia, a potentially life-
threatening condition in which the red blood cells are destroyed.
